Advertisement
BAX vs BRO
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BAX is a Hold and BRO is a Buy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
BAX’s FA Score shows that 0 FA rating(s) are green whileBRO’s FA Score has 1 green FA rating(s).
- BAX’s FA Score: 0 green, 5 red.
- BRO’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
BAX’s TA Score shows that 3 TA indicator(s) are bullish while BRO’s TA Score has 4 bullish TA indicator(s).
- BAX’s TA Score: 3 bullish, 6 bearish.
- BRO’s TA Score: 4 bullish, 4 bearish.
Price Growth
BAX (@Medical Specialties) experienced а -7.86% price change this week, while BRO (@Insurance Brokers/Services) price change was -0.93% for the same time period.
The average weekly price growth across all stocks in the @Medical Specialties industry was -1.00%. For the same industry, the average monthly price growth was +1.59%, and the average quarterly price growth was -1.40%.
The average weekly price growth across all stocks in the @Insurance Brokers/Services industry was +0.44%. For the same industry, the average monthly price growth was +10.89%, and the average quarterly price growth was -24.04%.
Reported Earning Dates
BAX is expected to report earnings on Oct 30, 2025.
BRO is expected to report earnings on Oct 27, 2025.
Industries' Descriptions
@Medical Specialties (-1.00% weekly)Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
@Insurance Brokers/Services (+0.44% weekly)Insurance brokers sell, solicit, or negotiate insurance for compensation. General insurance brokers mostly cater to insurances on car, house etc. (versus life). Brokers are also often instrumental in helping small employers find health insurance, particularly in more competitive markets. Additionally, brokers may also provide risk assessments, insurance consulting services, insurance-related regulatory and legislative update services. Some of the major names in this industry include Marsh & McLennan Companies, Inc., Aon plc and Verisk Analytics Inc.
| BAX | BRO | BAX / BRO | |
| Capitalization | 21.8B | 24.6B | 89% |
| EBITDA | 1.67B | 1.55B | 108% |
| Gain YTD | -2.107 | 4.435 | -48% |
| P/E Ratio | 85.61 | 28.30 | 302% |
| Revenue | 14.8B | 4.2B | 352% |
| Total Cash | 3.19B | 711M | 449% |
| Total Debt | 14.4B | 4.02B | 358% |
BAX | BRO | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 55 | 79 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 50 Fair valued | 50 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | 6 | |
SMR RATING 1..100 | 100 | 100 | |
PRICE GROWTH RATING 1..100 | 62 | 57 | |
P/E GROWTH RATING 1..100 | 100 | 100 | |
SEASONALITY SCORE 1..100 | n/a | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
BAX's Valuation (50) in the Medical Specialties industry is in the same range as BRO (50) in the Insurance Brokers Or Services industry. This means that BAX’s stock grew similarly to BRO’s over the last 12 months.
BRO's Profit vs Risk Rating (6) in the Insurance Brokers Or Services industry is significantly better than the same rating for BAX (100) in the Medical Specialties industry. This means that BRO’s stock grew significantly faster than BAX’s over the last 12 months.
BRO's SMR Rating (100) in the Insurance Brokers Or Services industry is in the same range as BAX (100) in the Medical Specialties industry. This means that BRO’s stock grew similarly to BAX’s over the last 12 months.
BRO's Price Growth Rating (57) in the Insurance Brokers Or Services industry is in the same range as BAX (62) in the Medical Specialties industry. This means that BRO’s stock grew similarly to BAX’s over the last 12 months.
BRO's P/E Growth Rating (100) in the Insurance Brokers Or Services industry is in the same range as BAX (100) in the Medical Specialties industry. This means that BRO’s stock grew similarly to BAX’s over the last 12 months.
| BAX | BRO | |
|---|---|---|
| RSI ODDS (%) | N/A | 1 day ago 70% |
| Stochastic ODDS (%) | 1 day ago 53% | 1 day ago 81% |
| Momentum ODDS (%) | 1 day ago 67% | 1 day ago 42% |
| MACD ODDS (%) | 1 day ago 59% | 1 day ago 44% |
| TrendWeek ODDS (%) | 1 day ago 60% | 1 day ago 46% |
| TrendMonth ODDS (%) | 1 day ago 62% | 1 day ago 58% |
| Advances ODDS (%) | 21 days ago 52% | 16 days ago 59% |
| Declines ODDS (%) | 1 day ago 58% | 5 days ago 46% |
| BollingerBands ODDS (%) | 1 day ago 62% | 5 days ago 61% |
| Aroon ODDS (%) | 1 day ago 54% | N/A |
Advertisement
BAX and
Correlation & Price change
A.I.dvisor indicates that over the last year, BAX has been loosely correlated with RVTY. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if BAX jumps, then RVTY could also see price increases.
BRO and
Correlation & Price change
A.I.dvisor indicates that over the last year, BRO has been closely correlated with AJG. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if BRO jumps, then AJG could also see price increases.